A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
Clinical trial NCT00863707 · COMPLETED
Trial details
- NCT number
- NCT00863707
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2009-12-01
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.